Skip to content

ADMA Biologics ADMA Increase Decrease In Deposits And Other Assets

Increase Decrease In Deposits And Other Assets at other companies

Amylyx Pharmaceuticals, Inc. logo
Amylyx Pharmaceuticals, Inc.AMLX
$494K+392%
DraftKings Inc. logo
DraftKings Inc.DKNG
-$1.14M-215%
Avista logo
AvistaAVA
-$2M+92.0%
Regions Financial logo
Regions FinancialRF
-$68M+66.7%
CleanSpark logo
CleanSparkCLSK
$18.5M-91.7%
Alpha Metallurgical Resources logo
Alpha Metallurgical ResourcesAMR
-$45.75K+55.1%

Other financials

Income statement

See full
Revenue$114.5M-0.3%
Gross profit$80.8M+32.2%
Operating income$58.3M+67.1%
Net income$45.3M+68.5%
EPS (diluted)$0.19+72.7%

Balance sheet

See full
Cash & equivalents$138.2M+92.9%
Total debt$204.4M+2,055%
Total equity$390.3M+4.5%
Total assets$665.2M+30.3%

Cash flow

See full
Operating cash flow$58.2M+396%
CapEx$2.5M-45.9%
Free cash flow$55.7M+329%

Valuation

See full
Market cap$2.02B-54.5%

Profitability

See full
Gross margin61.3%+8.7pp
Operating margin42.1%+9.0pp
Net margin32.4%-12.6pp
FCF margin21.2%+1.4pp

Returns & leverage

See full
Return on equity43.3%-35.2pp
Debt / equity0.5×+0.5×
Current ratio+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept adma:IncreaseDecreaseInDepositsAndOtherAssets.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's increase decrease in deposits and other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ADMA Biologics's increase decrease in deposits and other assets?
ADMA Biologics (ADMA) reported increase decrease in deposits and other assets of -$379K in Q1 2026.
How has ADMA Biologics's increase decrease in deposits and other assets changed year-over-year?
ADMA Biologics's increase decrease in deposits and other assets decreased by 215.8% year-over-year, from -$120K to -$379K.
What is the long-term trend for ADMA Biologics's increase decrease in deposits and other assets?
Over 3 years (2021 to 2025), ADMA Biologics's increase decrease in deposits and other assets has grown at a -46.0% compound annual growth rate (CAGR), from $1.78M to -$279K.
What does increase decrease in deposits and other assets mean?
Captures the net change in non-current deposits and miscellaneous assets that do not fall into standard working capital categories. Fluctuations here can indicate changes in long-term operational commitments or security deposits required for business facilities.